Literature DB >> 19475618

TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.

Eva Askar1, Rusudan Bregadze, Jasmin Mertens, Stefan Schweyer, Albert Rosenberger, Giuliano Ramadori, Sabine Mihm.   

Abstract

Phenotypes of liver disease due to chronic hepatitis C virus (HCV) infection show a wide range of variations in terms of histological manifestations and the clinical outcome. Sensing of viral double-stranded RNA (dsRNA) by Toll-like receptor 3 (TLR3) is likely involved in early pathogen detection and the host response to viral infection. This study analyzed epidemiological and clinical data from a total of 137 patients with chronic HCV infection with regard to two polymorphic positions within the TLR3 gene: rs5743305 (T/A) is located within the promoter region and might affect transcriptional activity, rs3775291 (C/T) is a non-synonymous single nucleotide polymorphism (SNP) located within exon 4 and the variant receptor has been shown to be functionally impaired. TLR3 promoter and the exon 4 variations were not found to be associated with TLR3 gene expression in peripheral blood mononuclear cells (PBMCs). In the liver, however, a tendency of higher TLR3 gene expression was found for exon 4 TT genotypes. Both variations were not found to be associated with clinical parameters of chronic disease. On the other hand, an analysis of the TLR3 exon 4 genotype distribution with respect to HCV subtype revealed an absence of TT genotype among HCV subtype 1a infected individuals. This study thus failed to reveal any association of the two SNPs under investigation with clinical parameters of chronic hepatitis C. However, data argue for a functional relevance of the exon 4 SNP in terms of conferring a different susceptibility towards HCV subtype infection. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475618     DOI: 10.1002/jmv.21491

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

Review 1.  Toll-like receptors in innate immunity and infectious diseases.

Authors:  Min-Hao Wu; Ping Zhang; Xi Huang
Journal:  Front Med China       Date:  2010-12-02

Review 2.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

3.  Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection.

Authors:  Eva Askar; Giuliano Ramadori; Sabine Mihm
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

4.  Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.

Authors:  Rania A Zayed; Dalia Omran; Doha A Mokhtar; Zinab Zakaria; Sameera Ezzat; Mohamed A Soliman; Lamiaa Mobarak; Hossam El-Sweesy; Ghada Emam
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

5.  A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection.

Authors:  Elin Kindberg; Sirkka Vene; Aukse Mickiene; Åke Lundkvist; Lars Lindquist; Lennart Svensson
Journal:  J Infect Dis       Date:  2011-01-07       Impact factor: 5.226

6.  Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1.

Authors:  Rongsu Qi; Scott Hoose; Jessica Schreiter; Kirti V Sawant; Roberta Lamb; C T Ranjith-Kumar; Juliane Mills; Lani San Mateo; Jarrat L Jordan; C Cheng Kao
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 7.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

8.  Mutations in toll-like receptor 3 are associated with elevated levels of rotavirus-specific IgG antibodies in IgA-deficient but not IgA-sufficient individuals.

Authors:  Gökçe Günaydın; Johan Nordgren; Lennart Svensson; Lennart Hammarström
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

9.  Toll-like receptor 3 in liver diseases.

Authors:  Shi Yin; Bin Gao
Journal:  Gastroenterol Res Pract       Date:  2010-09-23       Impact factor: 2.260

10.  Promoter region polymorphism & expression profile of toll like receptor-3 (TLR-3) gene in chronic hepatitis C virus (HCV) patients from India.

Authors:  Subhash Medhi; Manab Deka; Purabi Deka; Shyam S Swargiary; Rajib K Hazam; Manash P Sharma; Phani K Gumma; Mohammad Asim; P Kar
Journal:  Indian J Med Res       Date:  2011-08       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.